世界の抗肥満治療薬市場予測（～2028年）：末梢性抗肥満薬、中枢性抗肥満薬

• 英文タイトル：Global Anti-obesity Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8737 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

抗肥満治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の抗肥満治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 抗肥満治療薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・末梢性抗肥満薬、中枢性抗肥満薬 用途別セグメントは次のように区分されます。 ・子供用、大人用 世界の抗肥満治療薬市場の主要な市場プレーヤーは以下のとおりです。 ・Merck、Novo Nordisk、Pfizer、Arena Pharmaceuticals、Roche、GlaxoSmithKline、Orexigen Therapeutics、Vivus、Amylin、Alizyme、Boehringer Ingelheim、Eisai 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、抗肥満治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な抗肥満治療薬メーカーの企業概要、2019年～2022年までの抗肥満治療薬の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な抗肥満治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別抗肥満治療薬の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの抗肥満治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での抗肥満治療薬市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および抗肥満治療薬の産業チェーンを掲載しています。 ・第13、14、15章では、抗肥満治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Merck、Novo Nordisk、Pfizer、Arena Pharmaceuticals、Roche、GlaxoSmithKline、Orexigen Therapeutics、Vivus、Amylin、Alizyme、Boehringer Ingelheim、Eisai ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：末梢性抗肥満薬、中枢性抗肥満薬 ・用途別分析2017年-2028年：子供用、大人用 ・抗肥満治療薬の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・抗肥満治療薬のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗肥満治療薬のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗肥満治療薬の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・抗肥満治療薬の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Anti-obesity Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Anti-obesity Drugs market size is estimated to be worth US$ 1876.9 million in 2021 and is forecast to a readjusted size of USD 5385.2 million by 2028 with a CAGR of 16.2% during review period. Kids accounting for % of the Anti-obesity Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Peripherally Acting Anti-obesity Drugs segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Anti-obesity Drugs include Merck, Novo Nordisk, Pfizer, Arena Pharmaceuticals, and Roche, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Anti-obesity Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Market segment by Application can be divided into
Kids
Adults
The key market players for global Anti-obesity Drugs market are listed below:
Merck
Novo Nordisk
Pfizer
Arena Pharmaceuticals
Roche
GlaxoSmithKline
Orexigen Therapeutics
Vivus
Amylin
Alizyme
Boehringer Ingelheim
Eisai
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-obesity Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti-obesity Drugs, with price, sales, revenue and global market share of Anti-obesity Drugs from 2019 to 2022.
Chapter 3, the Anti-obesity Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-obesity Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Anti-obesity Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti-obesity Drugs.
Chapter 13, 14, and 15, to describe Anti-obesity Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Anti-obesity Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-obesity Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Peripherally Acting Anti-obesity Drugs
1.2.3 Centrally Acting Anti-obesity Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-obesity Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Kids
1.3.3 Adults
1.4 Global Anti-obesity Drugs Market Size & Forecast
1.4.1 Global Anti-obesity Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Anti-obesity Drugs Sales in Volume (2017-2028)
1.4.3 Global Anti-obesity Drugs Price (2017-2028)
1.5 Global Anti-obesity Drugs Production Capacity Analysis
1.5.1 Global Anti-obesity Drugs Total Production Capacity (2017-2028)
1.5.2 Global Anti-obesity Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti-obesity Drugs Market Drivers
1.6.2 Anti-obesity Drugs Market Restraints
1.6.3 Anti-obesity Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Anti-obesity Drugs Product and Services
2.1.4 Merck Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Novo Nordisk
2.2.1 Novo Nordisk Details
2.2.2 Novo Nordisk Major Business
2.2.3 Novo Nordisk Anti-obesity Drugs Product and Services
2.2.4 Novo Nordisk Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Anti-obesity Drugs Product and Services
2.3.4 Pfizer Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Arena Pharmaceuticals
2.4.1 Arena Pharmaceuticals Details
2.4.2 Arena Pharmaceuticals Major Business
2.4.3 Arena Pharmaceuticals Anti-obesity Drugs Product and Services
2.4.4 Arena Pharmaceuticals Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Anti-obesity Drugs Product and Services
2.5.4 Roche Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Anti-obesity Drugs Product and Services
2.6.4 GlaxoSmithKline Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Orexigen Therapeutics
2.7.1 Orexigen Therapeutics Details
2.7.2 Orexigen Therapeutics Major Business
2.7.3 Orexigen Therapeutics Anti-obesity Drugs Product and Services
2.7.4 Orexigen Therapeutics Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Vivus
2.8.1 Vivus Details
2.8.2 Vivus Major Business
2.8.3 Vivus Anti-obesity Drugs Product and Services
2.8.4 Vivus Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Amylin
2.9.1 Amylin Details
2.9.2 Amylin Major Business
2.9.3 Amylin Anti-obesity Drugs Product and Services
2.9.4 Amylin Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Alizyme
2.10.1 Alizyme Details
2.10.2 Alizyme Major Business
2.10.3 Alizyme Anti-obesity Drugs Product and Services
2.10.4 Alizyme Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Boehringer Ingelheim
2.11.1 Boehringer Ingelheim Details
2.11.2 Boehringer Ingelheim Major Business
2.11.3 Boehringer Ingelheim Anti-obesity Drugs Product and Services
2.11.4 Boehringer Ingelheim Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Eisai
2.12.1 Eisai Details
2.12.2 Eisai Major Business
2.12.3 Eisai Anti-obesity Drugs Product and Services
2.12.4 Eisai Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Anti-obesity Drugs Breakdown Data by Manufacturer
3.1 Global Anti-obesity Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Anti-obesity Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Anti-obesity Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Anti-obesity Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Anti-obesity Drugs Manufacturer Market Share in 2021
3.5 Global Anti-obesity Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Anti-obesity Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anti-obesity Drugs Market Size by Region
4.1.1 Global Anti-obesity Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Anti-obesity Drugs Revenue by Region (2017-2028)
4.2 North America Anti-obesity Drugs Revenue (2017-2028)
4.3 Europe Anti-obesity Drugs Revenue (2017-2028)
4.4 Asia-Pacific Anti-obesity Drugs Revenue (2017-2028)
4.5 South America Anti-obesity Drugs Revenue (2017-2028)
4.6 Middle East and Africa Anti-obesity Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Anti-obesity Drugs Sales in Volume by Type (2017-2028)
5.2 Global Anti-obesity Drugs Revenue by Type (2017-2028)
5.3 Global Anti-obesity Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Anti-obesity Drugs Sales in Volume by Application (2017-2028)
6.2 Global Anti-obesity Drugs Revenue by Application (2017-2028)
6.3 Global Anti-obesity Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Anti-obesity Drugs Sales by Type (2017-2028)
7.2 North America Anti-obesity Drugs Sales by Application (2017-2028)
7.3 North America Anti-obesity Drugs Market Size by Country
7.3.1 North America Anti-obesity Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Anti-obesity Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Anti-obesity Drugs Sales by Type (2017-2028)
8.2 Europe Anti-obesity Drugs Sales by Application (2017-2028)
8.3 Europe Anti-obesity Drugs Market Size by Country
8.3.1 Europe Anti-obesity Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Anti-obesity Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Anti-obesity Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Anti-obesity Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Anti-obesity Drugs Market Size by Region
9.3.1 Asia-Pacific Anti-obesity Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Anti-obesity Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Anti-obesity Drugs Sales by Type (2017-2028)
10.2 South America Anti-obesity Drugs Sales by Application (2017-2028)
10.3 South America Anti-obesity Drugs Market Size by Country
10.3.1 South America Anti-obesity Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Anti-obesity Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anti-obesity Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Anti-obesity Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Anti-obesity Drugs Market Size by Country
11.3.1 Middle East & Africa Anti-obesity Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Anti-obesity Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Anti-obesity Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Anti-obesity Drugs
12.3 Anti-obesity Drugs Production Process
12.4 Anti-obesity Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Anti-obesity Drugs Typical Distributors
13.3 Anti-obesity Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---